Odyssey

is a Massachusetts-based biotechnology company that researches and develops immunomodulators and oncology medicines for the treatment of inflammatory diseases...
Read more
Odyssey President & CEO: Gary D. Glick

President & CEO

Gary D. Glick

CEO Approval Rating

86/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
100-250
Agree?
Funding
$583.6M
Acquisitions
1

Odyssey Competitors

1CalciMedica
2Evommune
3Qu Biologics
4bluebird bio
5Jounce
6NexImmune
7Juno Therapeutics
8Kite Pharma
9Cimt | Association For Cancer Immunotherapy
10Sorrento

Trending Companies